BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

10:01 AM
 | 
Aug 10, 2017
 |  BC Week In Review  |  Clinical News  |  Regulatory

FDA approves Eisai's seizure drug Fycompa for monotherapy use

FDA approved an sNDA from Eisai Co. Ltd. (Tokyo:4523) for Fycompa perampanel (E2007) as monotherapy to treat partial-onset seizures with...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >